Journal of the American Medical Association

Pfizer COVID Vax Costs $110 to $130 Per Dose

Reports indicate this pricing will offer years of revenue boost for the company.

Feds Reject Florida Surgeon General’s Warnings About Dangers of mRNA Vaccinations

On October 7, Florida Surgeon General Dr. Joseph Ladapo issued guidance for mRNA COVID-19 vaccines, stating that with "a high level of global immunity to COVID-19, the benefit of vaccination is likely outweighed by this abnormally high risk of cardiac-related death among men" in the 18-39 age group.

An Utterly Unexpected Risk Factor for Malignant Melanoma

In 1985, Lydia Temshok and her colleagues made a surprising discovery—some facets of personality were found to be related to cancer prognosis.

Pharma’s Criminal Business Model — And How the U.S. Government Benefits From It

In early September, the U.S. Department of Justice (DOJ) announced that pharma giant Bayer would have to fork over millions to the DOJ to resolve allegations of fraud under the False Claims Act (FCA).

4X Vaxxed New Mexico Gov. Tests Positive for COVID

"Get vaccinated & boosted," Gov. Grisham wrote on Twitter, despite being fully vaccinated and still catching COVID.

As COVID Vaccine Injuries Pile Up, It’s Worth Remembering: Medicine Is a Leading Cause of Death in the U.S.

In his 1974 book and accompanying article with the shared title of “Medical Nemesis,” philosopher and theologian Ivan Illich boldly asserted that medical professional practice and related health policies, which he characterized as “both industry and religion,” had become “a major threat to health.”

‘Mind-Boggling Negligence’: How the Feds Consistently Got COVID Wrong

From masks and distancing to vaccines and therapeutics, federal pronouncements and actions have confidently rebuffed contrary evidence before sometimes — quietly — coming around.

The More Vaccines You Take, The More Likely You Will Catch COVID Again: JAMA

Those who received no COVID-19 vaccine were less likely to become reinfected.

FDA Authorizes Pfizer Booster for Kids 5 to 11, Bypasses Advisory Panel

The U.S. Food and Drug Administration (FDA) today authorized a booster dose of the Pfizer-BioNTech COVID-19 vaccine for children ages 5 to 11, without convening its vaccine advisory panel of independent experts to discuss Pfizer’s data on 5- to 11-year-olds — and based on a study subset of only 67 children, CNBC reported.

FDA Rubber-Stamps Remdesivir for Infants Without Evidence of Safety, Efficacy

The U.S. Food and Drug Administration (FDA) on Monday approved the use of the antiviral therapy, remdesivir, to treat COVID-19 in infants four weeks and older.

Latest news

- Advertisement -spot_img